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Abstract
Background: Rats emit 50-kHz ultrasonic vocalizations (USVs) to communicate positive emotional states, and these USVs are 
increasingly being investigated in preclinical studies on reward and motivation. Although it is the activation of dopamine 
receptors that initiates the emission of 50-kHz USVs, non-dopaminergic mechanisms may modulate calling in the 50 kHz 
frequency band. To further elucidate these mechanisms, the present study investigated whether the pharmacological 
manipulation of glucocorticoid signaling influenced calling.
Methods: Rats were administered corticosterone (1–5 mg/kg, s.c.), the glucocorticoid receptor antagonist mifepristone (40 or 
100 mg/kg, s.c.), or the corticosterone synthesis inhibitor metyrapone (50 or 100 mg/kg, i.p.). The effects of these drugs on 
calling initiation and on calling recorded during nonaggressive social contacts or after the administration of amphetamine 
(0.25 or 1 mg/kg, i.p.) were then evaluated.
Results: Corticosterone failed to initiate the emission of 50-kHz USVs and did not influence pro-social and amphetamine-
stimulated calling. Similarly, mifepristone and metyrapone did not initiate calling. However, metyrapone suppressed pro-
social calling and calling stimulated by a moderate dose (1 mg/kg, i.p.) of amphetamine. Conversely, mifepristone attenuated 
calling stimulated by a low (0.25 mg/kg, i.p.), but not moderate (1 mg/kg, i.p.), dose of amphetamine and had no influence on 
pro-social calling.
Conclusions: The present results demonstrate that glucocorticoid signaling modulates calling in the 50 kHz frequency 
band only in certain conditions and suggest that mechanisms different from the inhibition of corticosterone synthesis may 
participate in the suppression of calling by metyrapone.
Keywords: amphetamine, corticosterone, metyrapone, mifepristone, rat communication
Introduction
Rats emit the so-called 50-kHz ultrasonic vocalizations (USVs), 
which are acoustic signals contained within the 35- to 80-kHz 
frequency range, to communicate positive emotional states to 
conspecifics (Panksepp, 2005; Schwarting et al., 2007; Brudzynski, 
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2013, 2015). On this basis, preclinical studies on reward and 
motivation are increasingly investigating the situations that 
are associated with calling in the 50 kHz frequency band and 
the mechanisms that underlie this behavior (Barker et al., 2015; 
Rippberger et al., 2015; Simola, 2015).
The emission of 50-kHz USVs is initiated by the activation of 
dopamine (DA) receptors in the shell of the nucleus accumbens 
(NAc) (Burgdorf et al., 2001; Thompson et al., 2006). Nevertheless, 
either the activation or the antagonism of nondopaminergic 
receptors may modulate calling in the 50 kHz frequency band (Fu 
and Brudzynski, 1994; Wright et al., 2012; Costa et al., 2015; Hamed 
et al., 2015; Wöhr et al., 2015; Simola et al., 2010, 2014, 2016). In this 
regard, it is noteworthy that rewarding stimuli of a different nature 
may elevate the plasma levels of corticosterone in rats (Szechtman 
et al., 1974; Knych and Eisenberg, 1979; Moldow and Fischman, 
1987; Buwalda et al., 2012; Egan and Ulrich-Lai, 2015). Endogenous 
corticosterone, in turn, modulates the release of DA in the NAc 
shell that is elicited by rewarding stimuli (Barrot et al., 2000). 
Moreover, additional studies indicate that the administration of 
exogenous corticosterone may stimulate DA release in the NAc 
shell and may shape the effects that rewarding stimuli elicit on the 
emotional state of rats (Piazza et al., 1991; Piazza and LeMoal, 1996; 
Pecoraro et al., 2005; Der-Avakian et al., 2006). Taken together, these 
findings may suggest that glucocorticoid receptors could modulate 
calling in rats that are exposed to rewarding stimuli.
To date, the only studies that provide some evidence of a pos-
sible relationship between glucocorticoid signaling and calling 
in the 50 kHz frequency band were performed in rats previously 
and repeatedly exposed to stress, which elevates the plasma lev-
els of corticosterone (Smith and Gala, 1977; Giralt et al., 1987). 
Thus, stress-exposed rats emitted a lower number of 50-kHz 
USVs in situations that may be rewarding, such as heterospecific 
playful contacts (“tickling”) or amphetamine administration, 
compared with stress-naïve rats (Popik et al., 2012, 2014; Kõiv 
et al., 2016). Moreover, administration of the corticosterone syn-
thesis inhibitor metyrapone during stress imposition restored 
calling in response to tickling (Popik et al., 2014). Nevertheless, 
it has to be remarked that some of the behavioral effects of 
stress do not depend on the elevation in plasma corticosterone 
(Ulrich-Lai and Herman, 2009; Mei and Li, 2013). Besides, a pre-
vious study has found high levels of calling in stress-naïve rats 
that were placed in an enriched environment, a situation that 
elevates the plasma levels of corticosterone (Perez-Sepulveda 
et al., 2013). However, that study did not clarify whether it was 
the activation of glucocorticoid receptors by corticosterone that 
enhanced calling. Therefore, investigating how glucocorticoid 
signaling modulates the emission of 50-kHz USVs in stress-
naïve rats appears to be relevant. Elucidating this issue may fur-
ther clarify the mechanisms that participate in calling, as well 
as the interplay between corticosterone and positive affect.
To this end, we administered corticosterone, the glucocortic-
oid receptor antagonist mifepristone, or the corticosterone 
synthesis inhibitor metyrapone to rats. Afterwards, we evalu-
ated whether these drugs initiated the emission of 50-kHz USVs 
and/or affected calling that was recorded during nonaggressive 
social contacts or after the administration of amphetamine, 
two situations that may be rewarding for rats (Burgdorf et al., 
2001, 2009). Moreover, we evaluated whether the administra-
tion of spironolactone, an antagonist of the mineralocorticoid 
receptors, affected pro-social and amphetamine-stimulated 
calling to investigate the mechanisms underlying the effects of 
metyrapone. In fact, metyrapone may have a greater inhibitory 
effect on the synthesis of the mineralocorticoid hormone aldos-
terone than on the synthesis of corticosterone (Rigel et al., 2010; 
Daniel and Newell-Price, 2015).
Methods
Animals
A total of 110 male Sprague–Dawley rats (Harlan, Italy) weigh-
ing 150 to 200 g at the beginning of the experiments were used. 
Rats were housed in groups of 4 to 6 in standard polycarbonate 
cages with sawdust bedding and maintained on a 12-hour-light/
dark cycle (lights on at 8:00 am). Food and water were freely 
available, except during USV recordings, which were performed 
between 12:00 and 4:00 pm. All experiments were conducted in 
accordance with the guidelines for animal experimentation of 
the EU directives (2010/63/EU; L.276; 22/09/2010) and with the 
guidelines approved by the Ethical Committee of the University 
of Cagliari. Experiments were designed to minimize animal dis-
comfort to the least extent possible and to reduce the number 
of animals used.
Doses and Administration Times of Drugs
Corticosterone, mifepristone, and spironolactone were pur-
chased from Sequoia Research Products Ltd. D-amphetamine 
(sulfate) and metyrapone were purchased from Sigma-Aldrich. 
Corticosterone, mifepristone, and spironolactone were dissolved 
in 10:90% dimethyl sulfoxide (DMSO)/polyethylene glycol (PEG). 
Corticosterone was administered at doses of 1, 2.5, or 5 mg/kg 
(Deroche et al., 1992, 1997; Dietz et al., 2007; Mantsch et al., 1998; 
Mei and Li, 2013). Mifepristone was administered at doses of 
40 or 100 mg/kg (Heikinheimo et al., 1994; De Vries et al., 1996). 
Spironolactone was administered at doses of 50 or 75  mg/kg 
(Achterberg et  al., 2014). Metyrapone was dissolved in 40:60% 
PEG/distilled water and administered at doses of 50 or 100 mg/
kg (Calvo et al., 1998; Wright et al., 2006). Amphetamine was dis-
solved in distilled water and administered at doses of 0.25 or 
1 mg/kg, both calculated as salt (Simola and Morelli, 2015; Wright 
et  al., 2010). Corticosterone, mifepristone, and spironolactone 
were administered s.c. in a volume of 1  mL/kg. Amphetamine 
and metyrapone were administered i.p. in a volume of 3 mL/kg.
Significance Statement
Ultrasonic vocalizations (USVs) of 50 kHz are a behavioral marker of reward in rats and are increasingly being investigated 
in preclinical studies on affect and emotion. On this basis, it appears of interest to elucidate the mechanisms that 
participate in the emission of 50-kHz USVs. Several preclinical and clinical studies indicate that glucocorticoid receptors 
may play a major role in the regulation of the emotional state. Therefore, we evaluated whether the emission of 50-kHz 
USVs could be influenced by drugs that modulate glucocorticoid-mediated signaling. The results of this study may be 
relevant not only to further elucidate the neuropharmacology of 50-kHz USVs, but also may provide further insight into 
the interplay between glucocorticoids and positive affect.
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Corticosterone (or its vehicle) was administered immediately 
before recordings in the experiments that evaluated calling ini-
tiation, or 10 minutes before recordings in the experiments 
that evaluated pro-social and amphetamine-stimulated calling 
(Der-Avakian et al., 2006; Scherer et al., 2011). Metyrapone (or its 
vehicle) was always administered 90 minutes before recordings 
(Calvo et al., 1998; Wright et al., 2006). Mifepristone and spirono-
lactone (or their vehicle) were always administered 45 minutes 
before recordings (De Vries et  al., 1996; Fiancette et  al., 2010; 
Mei and Li, 2013; Achterberg et  al., 2014; Hofford et  al., 2015). 
Amphetamine was always administered immediately before 
recordings (Simola et  al., 2012). The supplementary Methods 
describe how the doses and administration times of drugs were 
selected.
Experimental Plan
A series of experiments was performed to evaluate whether the 
pharmacological manipulation of glucocorticoid signaling influ-
enced the emission of 50-kHz USVs in different conditions. Rats 
Figure 1. Timeline of the experiments. Four sets of rats were used in this study, and the figure indicates the experiments performed in each set of rats. In the first 
week, rats in each set were individually housed during recordings. They were habituated (30 minutes) to the test cage on day 1, to evaluate basal calling, and received 
vehicle (10:90% dimethyl sulfoxide [DMSO]/polyethylene glycol [PEG]) on day 2. Afterwards, rats received pharmacological treatments and were housed either individu-
ally or in pairs during recording, as outlined in the figure. Ultrasonic vocalization (USV) recordings were performed on each testing day and lasted for 2 hours in rats 
individually housed and 15 minutes in rats housed in pairs. A, amphetamine; C, corticosterone; H, habituation to the test-cage; ME, metyrapone; MI, mifepristone; SP, 
spironolactone; V, vehicle. The numbers indicate the doses of each drug (in mg/kg). The effects of metyrapone, mifepristone, and spironolactone on calling initiation 
were evaluated in experiment 2b and 3b, before the administration of amphetamine.
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received the repeated administration of one or two of the follow-
ing drugs: corticosterone, metyrapone, mifepristone, and spir-
onolactone. Each drug was administered alone or in combination 
with amphetamine. Repeated drug administrations in the same 
rats were performed to reduce the number of animals used in 
the study. Moreover, drugs were always given at ascending doses. 
This was done to expose rats to the same experimental condi-
tions across recordings in the attempt to reduce the variability of 
the results. Finally, 4 sets of rats were used to reduce the possible 
carryover effects that could arise from repeated drug administra-
tion. Rats in each set were drug-naïve before the beginning of the 
experiments. The individual experiments are listed below and 
are grouped according to the drugs administered. The timeline of 
experiments performed in each set of rats is described in Figure 1.
Experiments That Evaluated the Effects of Corticosterone on 
Calling in the 50 kHz Band
Experiment 1a: calling initiation. Rats were individually housed 
during recordings and received the acute administration of cor-
ticosterone (1, 2.5, or 5  mg/kg, s.c.) (Figure  1A). n = 10 for each 
dose of corticosterone.
Experiment 1b: pro-social calling. Rats were housed in pairs dur-
ing recordings to engage in social contacts and evaluated for 3 
consecutive weeks. In each week, rats received vehicle (10:90%, 
DMSO:PEG) on the first day and corticosterone (1, 2.5, or 5 mg/kg, 
s.c.) on the fourth day (Figure 1A). n = 15 pairs for each evaluation.
Experiments 1c and d: amphetamine-stimulated calling. Rats 
were individually housed during recordings and evaluated for 
3 consecutive weeks. In each week, rats received corticosterone 
(1, 2.5, or 5  mg/kg, s.c.) followed by amphetamine 10 minutes 
later. Amphetamine was administered at either a moderate dose 
(1 mg/kg, i.p.) (Figure 1B) or low dose (0.25 mg/kg, i.p.) (Figure 1D). 
n = 10 for each dose of corticosterone.
Experiments That Evaluated the Effects of Metyrapone on 
Calling in the 50 kHz Band
Experiment 2a: pro-social calling. Rats were housed in pairs dur-
ing recordings to engage in social contacts and evaluated for 2 
consecutive weeks. In each week, rats received vehicle (40:60%, 
PEG: distilled water) on the first day and metyrapone (50 or 
100  mg/kg, s.c.) on the fourth day (Figure  1A). n = 15 pairs for 
each evaluation.
Experiment 2b: calling initiation and amphetamine-stimulated call-
ing. Rats were individually housed during recordings and eval-
uated for 2 consecutive weeks. In the first week, all rats were 
administered vehicle (40:60% PEG: distilled water), placed in the 
test cage for 90 minutes, and thereafter received amphetamine 
(1 mg/kg, i.p.) to obtain a baseline level of calling. In the second 
week, rats were administered metyrapone (50 or 100 mg/kg, i.p., 
n = 10 for each dose) and placed in the test cage for 90 minutes 
to evaluate calling initiation. Thereafter, metyrapone-treated 
rats received a moderate dose of amphetamine (1  mg/kg, i.p.) 
(Figure 1B).
Experiments That Evaluated the Effects of Mifepristone and 
Spironolactone on Calling in the 50 kHz Band
Experiment 3a: pro-social calling. Rats were housed in pairs dur-
ing recordings to engage in social contacts and evaluated for 3 
consecutive weeks. In each week, rats received vehicle (10:90%, 
DMSO:PEG) and either mifepristone (40 or 100 mg/kg, s.c.) or spir-
onolactone (50 or 75 mg/kg, s.c.) on the fourth day (Figure 1C). 
n = 10 pairs for each evaluation.
Experiment 3b: calling initiation and amphetamine-stimulated 
calling. Rats were individually housed during recordings and 
evaluated for 2 consecutive weeks. In the first week, all rats 
were administered vehicle (10:90%, DMSO:PEG), placed in the 
test cage for 45 minutes, and thereafter received amphetamine 
(1 mg/kg, i.p.) to obtain a baseline level of calling. In the second 
week, rats were administered either mifepristone (40 or 100 mg/
kg, s.c., n = 10 for each dose) or spironolactone (50 or 75 mg/kg, 
s.c., n = 10 for each dose) and placed in the test cage for 45 min-
utes to evaluate calling initiation. Thereafter, mifepristone- and 
spironolactone-treated rats received a moderate dose of am-
phetamine (1 mg/kg, i.p., Figure 1C).
Experiment 3c: calling stimulated by a low dose of amphetamine. 
Rats were individually housed during recordings and evaluated 
for 2 consecutive weeks. In the first week, rats were treated 
as described for experiment 3b. In the second week, rats were 
treated with mifepristone (100 mg/kg, s.c., n = 20), placed in the 
test cage for 45 minutes, and thereafter received a low dose of 
amphetamine (0.25 mg/kg, i.p., Figure 1D).
In all the experiments that evaluated pro-social calling, rats 
were always paired with a different rat and both rats were taken 
from different cages.
Recording of USVs
Rats were placed in Plexiglas cylinders (diameter, 25 cm; height, 
30 cm). Thereafter, USVs were recorded by means of ultrasonic 
devices (CM16/CMPA microphones, UltraSoundGate 116 Hb; 
Avisoft), as described elsewhere (Simola et al., 2012). Recordings 
lasted for 2 hours in rats individually housed and 15 minutes in 
rats housed in pairs. All the recording times were subdivided into 
5-minute intervals. The supplementary Methods report further 
details on the recording procedures. Supplementary Figure  1 
shows some examples of 50-kHz USVs recorded in this study.
Statistical Analysis
USV recordings were converted into spectrograms by means of 
the software SASLab Pro 4.52 (Avisoft) with the following set-
tings: 512 Fast Fourier Transform-length, Hamming window, and 
75% overlap frame set-up. Spectrograms were visually inspected 
by an experienced experimenter, and SASLab Pro 4.52 was used 
to calculate the number of vocalizations after manual clean-
ing of all the signals that could not be univocally classified as 
50-kHz USVs (Simola et al., 2012).
Means ± SEM of the numbers of 50-kHz USVs were calculated 
for all the experiments. USV data collected in each experiment 
were tested for normality and homoscedasticity with Levene’s 
test. Logarithmic transformation was applied to preserve homo-
scedasticity, when necessary. A constant of +1 was added to all 
data subjected to logarithmic transformation. Figures report raw 
data for clarity. The analysis of spontaneous calling recorded 
during habituation in each set of experiments revealed no outli-
ers (data not shown). Moreover, neither aggressive interactions 
between rats nor emission of aversive 22-kHz USVs (Brudzynski, 
2007) were observed in the present study. Therefore, all the rats 
used were included in the statistical analysis. The total number 
of calls emitted and the time course of calling was evaluated 
for each experiment with 2-way (treatment × time) ANOVA to 
reveal significant differences between pharmacological treat-
ments and vehicle administration. Moreover, data collected in 
each experiment were subdivided into low vocalization (LV) and 
high vocalization (HV) groups, based on the median value of the 
number of 50-kHz USVs emitted. Such a subdivision was done 
to clarify whether ceiling and/or floor effects could affect the 
results observed in all rats. Separate ANOVAs were run for all 
rats and for the LV and the HV groups of rats. Significance was 
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always set at P < .05 and ANOVAs were followed by Tukey’s post-
hoc tests, when appropriate. For the sake of conciseness, the 
main effects of ANOVA are reported in supplementary Table 1. 
Statistical results for the time course of calling recorded in each 
administration day are described in the legends of the sup-
plementary figures, when appropriate. Statistical analysis was 
performed with Statistica (Statsoft) and QI Macros (KnowWare 
International) for Windows.
Results
This section describes the effects of pharmacological treatment 
on the total number of 50-kHz USVs emitted in each testing day. 
Supplementary Figures 2 to 8 demonstrate the effects of phar-
macological treatment on the time course of calling in each 
testing day.
Effects of Corticosterone on Calling Initiation in Rats 
Individually Housed during Recording
Acute administration of corticosterone (1, 2.5, or 5 mg/kg, s.c.) 
did not modify the number of 50-kHz USVs emitted by rats, com-
pared with vehicle administration. Two-way ANOVA showed no 
significant effect of treatment (F5,53 = 1.41, P = .23) (Figure 2).
Effects of Corticosterone on Prosocial Calling in Rats 
Housed in Pairs during Recording
Administration of escalating doses of corticosterone (1, 2.5, or 
5 mg/kg, s.c., once a week) did not modify the number of 50-kHz 
USVs emitted by rats that were allowed to engage in social con-
tacts, compared with vehicle administration. Two-way ANOVA 
showed no significant effect of treatment (F5,84 = 0.31, P = .91) 
(Figure 3A).
Effects of Corticosterone on Calling Stimulated by 
Amphetamine in Rats Individually Housed during 
Recording
Repeated administration of a low dose of amphetamine (0.25 mg/
kg, i.p., once a week for 3 weeks) did not modify the number of 
50-kHz USVs emitted by rats compared with vehicle adminis-
tration. A similar lack of effect was observed when escalating 
doses of corticosterone (1–5 mg/kg, s.c.) were co-administered 
with amphetamine (0.25 mg/kg, i.p.). Two-way ANOVA showed 
no significant effect of treatment (F7,72 = 0.56, P = .79) (Figure 3B).
Conversely, repeated administration of a moderate dose 
of amphetamine (1  mg/kg, i.p., once a week for 3 weeks) sig-
nificantly modified the number of 50-kHz USVs emitted by rats, 
compared with vehicle administration. Similar effects were 
observed when escalating doses of corticosterone (1–5  mg/
kg, s.c.) were co-administered with amphetamine (1  mg/kg, 
i.p.). Two-way ANOVA showed a significant effect of treatment: 
(F7,72 = 29.82, P < .01). Tukey’s test showed that both amphetamine 
and corticosterone + amphetamine elevated the number of calls. 
However, corticosterone + amphetamine increased the number 
of 50-kHz USVs emitted in a fashion similar to amphetamine 
alone (Figure 3C).
Figure  2. Effects of corticosterone on calling initiation. Acute corticosterone 
(1–5 mg/kg, s.c.) did not initiate calling. The number of 50-kHz ultrasonic vocali-
zations (USVs) recorded after corticosterone administration was comparable 
with that recorded after vehicle administration. CORT, corticosterone; VEH, ve-
hicle. n = 10.
Figure  3. Effects of corticosterone on pro-social and amphetamine-stimulated 
calling. Escalating doses of corticosterone (1–5  mg/kg, s.c.) did not modify the 
number of 50-kHz USVs emitted by rats that were housed in pairs during record-
ing, compared with vehicle administration (A). Repeated administration of a low 
dose of amphetamine (0.25 mg/kg, i.p., once a week for 3 weeks) did not modify 
the number of 50-kHz ultrasonic vocalizations (USVs) emitted by rats that were 
individually housed during recording, compared with vehicle administration (B). 
Conversely, repeated administration of a moderate dose of amphetamine (1 mg/
kg, i.p., once a week for 3 weeks) significantly elevated the number of 50-kHz USVs 
emitted by rats that were individually housed during recording, compared with 
vehicle administration (C). Coadministration of escalating doses of corticosterone 
(1–5 mg/kg, s.c.) did not influence the effects of amphetamine on calling (B–C). 
adm., administration; AMPH, amphetamine; CORT, corticosterone; VEH, vehicle. 
* P < .05 vs VEH. n = 15 for rats housed in pairs. n = 10 for rats individually housed.
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Effects of Metyrapone on Calling Initiation in Rats 
Individually Housed during Recording
Acute administration of metyrapone (50 or 100  mg/kg, i.p.) 
did not modify the number of 50-kHz USVs emitted by rats, 
compared with vehicle administration. Two-way ANOVA 
showed no significant effect of treatment (F3,36 = 0.26, P = .86) 
(Figure 4A).
Effects of Metyrapone on Prosocial Calling in Rats 
Housed in Pairs during Recording
Administration of escalating doses of metyrapone (50 or 100 mg/
kg, i.p., once a week) modified the number of 50-kHz USVs emit-
ted by rats that were allowed to engage in social contacts, com-
pared with vehicle administration. Two-way ANOVA showed a 
significant effect of treatment (F3,56 = 72.96, P < .01). Moreover, 
Tukey’s test showed that metyrapone (100  mg/kg, i.p.) signifi-
cantly reduced the number of calls (Figure 5A).
Effects of Metyrapone on Calling Stimulated by 
Amphetamine in Rats Individually Housed  
during Recording
Co-administration of metyrapone (50 or 100 mg/kg, i.p.) modi-
fied the number of 50-kHz USVs emitted by rats that were 
treated with amphetamine (1 mg/kg, i.p.), compared with vehi-
cle co-administration. Two-way ANOVA showed a significant 
effect of treatment (F5,54 = 35.43, P < .01). Moreover, Tukey’s test 
showed that metyrapone (100 mg/kg, i.p.) significantly reduced 
the number of calls (Figure 5D).
Effects of Mifepristone and Spironolactone on 
Calling Initiation in Rats Individually Housed  
during Recording
Acute administration of mifepristone (40 or 100 mg/kg, s.c.) or 
spironolactone (50 or 75 mg/kg, s.c.) did not modify the number 
of 50-kHz USVs emitted by rats, compared with vehicle admin-
istration. Two-way ANOVA showed no significant effects of treat-
ment for mifepristone (F3,36 = 1.77, P = .17) and spironolactone 
(F3,36 = 0.46, P = .71) (Figure 4B–C).
Effects of Mifepristone and Spironolactone on 
Prosocial Calling in Rats Housed in Pairs  
during Recording
Administration of escalating doses of mifepristone (40 or 100 
mg/kg, s.c., once a week) or spironolactone (50 or 75 mg/kg, s.c., 
once a week) did not modify the number of 50-kHz USVs emit-
ted by rats that were allowed to engage in social contacts, com-
pared with vehicle administration. Two-way ANOVA showed no 
significant effect of treatment for mifepristone (F3,36 = 0.38, P = .77) 
and spironolactone (F3,36 = 0.50, P = .68) (Figure 5B–C).
Effects of Mifepristone and Spironolactone on 
Calling Stimulated by Amphetamine in Rats 
Individually Housed during Recording
Co-administration of mifepristone (40 or 100 mg/kg, s.c.) did 
not modify the number of 50-kHz USVs emitted by rats that 
were treated with amphetamine (1 mg/kg, i.p.), compared with 
vehicle co-administration. Thus, two-way ANOVA showed a sig-
nificant effect of treatment (F5,54 = 33.95, P < .01). However, Tukey’s 
test showed that mifepristone + amphetamine increased the 
number of 50-kHz USVs emitted in a fashion similar to amphet-
amine alone (Fig 5E). Nevertheless, co-administration of mife-
pristone (100 mg/kg, s.c.) influenced calling recorded after the 
administration of a low dose of amphetamine (0.25 mg/kg, i.p.) 
(see below).
Figure 4. Effects of metyrapone, mifepristone, and spironolactone on calling ini-
tiation. Acute metyrapone (50 or 100 mg/kg, i.p.) (A), mifepristone (40 or 100 mg/
kg, s.c.) (B), or spironolactone (50 or 75 mg/kg, s.c.) (C) did not initiate calling. The 
number of 50-kHz ultrasonic vocalizations (USVs) recorded after the adminis-
tration of each drug was comparable with that recorded after vehicle admin-
istration. METY, metyrapone; MIFE, mifepristone; SPIRO, spironolactone; VEH, 
vehicle. n = 10.
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Co-administration of spironolactone (50 or 75 mg/kg, s.c.) 
did not modify the number of 50-kHz USVs emitted by rats that 
were treated with amphetamine (1 mg/kg, i.p.), compared with 
vehicle co-administration. Thus, two-way ANOVA showed a sig-
nificant effect of treatment (F5,54 = 42.04, P < .01). However, Tukey’s 
test showed that spironolactone + amphetamine increased the 
number of 50-kHz USVs in a fashion similar to amphetamine 
alone (Figure 5F).
Emission of 50-kHz USVs in the LV and HV Groups 
of Rats
Co-administration of mifepristone (100  mg/kg, s.c.) modified 
the number of 50-kHz USVs emitted in the HV group of rats 
treated with a low dose of amphetamine (0.25 mg/kg, i.p.). Two-
way ANOVA showed a significant effect of treatment (F2,27 = 5.03, 
P = .01) (Figure 6). Moreover, Tukey’s test revealed that the number 
of calls emitted after mifepristone + amphetamine was lower 
than the number of calls emitted after amphetamine alone. The 
other results obtained in the LV and HV groups of rats were in 
line with the results obtained in the totality of rats (data not 
shown).
Discussion
The present study evaluated whether the pharmacological ma-
nipulation of glucocorticoid signaling initiated the emission of 
50-kHz USVs and/or influenced calling in situations that may be 
rewarding for rats. The results obtained showed that metyrapone 
and mifepristone affected calling, although mifepristone did so 
only in certain conditions. Conversely, corticosterone had no in-
fluence on calling.
Previous studies in rats have reported that corticosterone 
administration does not induce conditioned place preference 
(CPP) (Dietz et al., 2007; Mei and Li, 2013). These results would 
suggest that exogenous corticosterone does not elicit reward-
ing effects in the rat. In agreement with this view, the present 
study found that corticosterone administration did not initiate 
the emission of 50-kHz USVs, which are a behavioral marker 
of reward in rats (Panksepp, 2005; Schwarting et al., 2007; 
Brudzynski, 2013, 2015). Similarly, corticosterone administra-
tion did not affect calling during nonaggressive social contacts, 
a situation that may induce a positive emotional state in rats 
(Burgdorf et al., 2009). Besides, another previous investigation 
found that rats after co-administration of corticosterone and 
morphine, displayed a more marked CPP, compared with those 
that received morphine alone (Der-Avakian et al., 2006). This find-
ing would suggest that corticosterone may amplify the reward-
ing effects of morphine. However, corticosterone strengthened 
morphine-induced CPP in rats that were previously exposed 
to stress, but not in stress-naïve rats (Der-Avakian et al., 2006). 
Interestingly, we found that corticosterone administration did 
not affect calling in stress-naïve rats treated with amphetamine. 
Therefore, and taken together, the results of the present study 
may suggest that in stress-naïve rats corticosterone administra-
tion neither induces a positive emotional state nor amplifies the 
effects that rewarding stimuli have on the emotional state.
Similar to corticosterone, mifepristone administration did 
not initiate calling in the 50 kHz frequency band. This finding 
would suggest that the antagonism of glucocorticoid receptors 
does not induce a positive emotional state in rats. Nevertheless, 
mifepristone affected calling, as it reduced the number of 
50-kHz USVs emitted after amphetamine administration. In 
this regard, it is noteworthy that the suppression of endogenous 
corticosterone by adrenalectomy attenuates DA release in the 
NAc shell of rats treated with drugs of abuse (Barrot et al., 2000). 
Moreover, the activation of DA receptors in the NAc shell is 
the key mechanism that initiates calling (Burgdorf et al., 2001; 
Thompson et al., 2006). Therefore, it is conceivable that mife-
pristone reduced calling in amphetamine-treated rats, because 
it attenuated DA signaling in the NAc shell. However, mifepris-
tone affected calling only in the HV group of rats treated with 
a low dose of amphetamine (0.25 mg/kg). Hence, these results 
indicate that the antagonism of glucocorticoid receptors modu-
lates calling only in certain conditions.
Homospecific social contacts and amphetamine admin-
istration increase the plasma levels of corticosterone in rats 
(Knych and Eisenberg, 1979; File, 1980). Nevertheless, the rise in 
Figure 5. Effects of metyrapone, mifepristone, and spironolactone on pro-social and amphetamine-stimulated calling. Escalating doses of metyrapone (50 or 100 mg/
kg, i.p., once a week) almost completely suppressed the number of 50-kHz ultrasonic vocalizations (USVs) emitted by rats that were housed in pairs during recording, 
compared with vehicle administration (A). Conversely, escalating doses of mifepristone (40 or 100 mg/kg, s.c., once a week) or spironolactone (50 or 75 mg/kg, s.c., 
once a week) did not affect pro-social calling (B–C). In rats that were individually housed during recordings, co-administration of metyrapone (100 mg/kg, i.p.) almost 
completely suppressed the number of 50-kHz USVs recorded after the administration of amphetamine (1 mg/kg, i.p.), compared with vehicle co-administration (D). 
Conversely, co-administration of mifepristone (40 or 100 mg/kg, s.c.) or spironolactone (50 or 75 mg/kg, s.c.) had no influence on amphetamine-stimulated calling (E–F). 
AMPH, amphetamine; METY, metyrapone; MIFE, mifepristone; SPIRO, spironolactone; VEH, vehicle. *P < .05 vs VEH; #P < .05 vs VEH + AMPH. n = 10.
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plasma corticosterone might not necessarily predict the affect-
ive valence of stimuli. Conversely, it could reflect the metabolic 
demands of neuronal circuits subsequent to the behavioral 
activation that is induced by salient stimuli (Buwalda et  al., 
2012; Egan and Ulrich-Lai, 2015). In agreement with the latter 
view, it may be speculated that either the stimulation or the 
antagonism of glucocorticoid receptors would not modify the 
affective properties of rewarding stimuli in stress-naïve rats. 
This hypothesis may explain why corticosterone and mifepris-
tone did not affect calling during social contacts or after the 
administration of a moderate dose of amphetamine (1 mg/kg). 
Alternatively, it may be speculated that glucocorticoid recep-
tor activation by endogenous corticosterone is an ancillary 
mechanism that sustains calling in situations featuring the 
emission of a low number of 50-kHz USVs (i.e., the administra-
tion of a low amphetamine dose). Besides, it cannot be ruled 
out that glucocorticoid receptors influence calling emitted by 
stress-naïve rats in situations different from those evaluated 
here. In fact, corticosterone may elicit dissimilar effects on the 
emotional state of rats depending on the situations considered 
(Piazza et al., 1991, 1996; Deroche et al., 1997; Mantsch et al., 
1998; Pecoraro et al., 2005; Buwalda et al., 2012; Olausson et al., 
2013).
The present study also found that metyrapone did not 
initiate the emission of 50-kHz USVs when administered at 
doses that inhibit corticosterone synthesis in rats. However, 
metyrapone almost completely suppressed calling recorded 
during nonaggressive social contacts or after the adminis-
tration of a moderate dose of amphetamine (1 mg/kg). Since 
mifepristone did not affect calling in the same situations, 
we investigated whether mechanisms other than the inhib-
ition of corticosterone synthesis participated in the effects 
of metyrapone observed here. In particular, we evaluated the 
effects of mineralocorticoid receptor antagonism on calling in 
the 50 kHz frequency band. In fact, metyrapone inhibits the 
synthesis of the mineralocorticoid hormone aldosterone (Rigel 
et al., 2010; Daniel and Newell-Price, 2015). Moreover, studies 
in cocaine-treated mice have demonstrated that the mineralo-
corticoid receptor antagonist spironolactone may affect the 
emotional state (Fiancette et al., 2010). However, spironolac-
tone did not influence pro-social and amphetamine-stimu-
lated calling, and it also failed to initiate the emission of 50-kHz 
USVs. In this regard, it is noteworthy that metyrapone inhibits 
the synthesis of both corticosterone and aldosterone (Daniel 
and Newell-Price, 2015). Therefore, it could be hypothesized 
that mifepristone and spironolactone did not suppress calling 
because they partially reproduced the effects of metyrapone. 
However, we have found in preliminary experiments that the 
co-administration of mifepristone and spironolactone did 
not attenuate amphetamine-stimulated calling (see supple-
mentary Table 2). Moreover, previous studies have demon-
strated that metyrapone may exert extra-adrenal effects in 
rats (Shaham et al., 1997; Guerin et al., 2014; Schmoutz et al., 
2014). Therefore, we may suggest that mechanisms of actions 
other than the inhibition of steroidogenesis may participate 
in the suppression of calling by metyrapone. In this regard, it 
is also noteworthy that the present study employed a protocol 
of repeated metyrapone administration, at least in the rats 
that were housed in pairs during recording. Therefore, such 
an administration protocol could have favored the sensitiza-
tion in the inhibitory effects of metyrapone on steroidogenesis 
and/or the emergence of additional mechanisms of action of 
metyrapone.
The effects of metyrapone observed here may appear to be 
in contrast to earlier findings in rats exposed to immobiliza-
tion stress (Popik et al., 2014). Thus, rats that were previously 
and repeatedly immobilized emitted a lower number of 50-kHz 
USVs when later subjected to tickling, compared with stress-
naïve rats. Metyrapone administration concomitantly with 
immobilization did not further suppress tickling-stimulated 
calling, but rather restored it. Conversely, metyrapone did not 
affect tickling-stimulated calling in stress-naïve rats. In this 
regard, it is noteworthy that the study by Popik and cowork-
ers employed a protocol of repeated metyrapone administra-
tion throughout 7 consecutive days. Conversely, in the present 
study metyrapone was given in a single or double, but spaced, 
administration. Notably, spaced and continuous administra-
tion of metyrapone may elicit dissimilar behavioral effects in 
rats (Shaham et  al., 1997). Moreover, the study by Popik and 
coworkers evaluated the effects of metyrapone in a situation 
(tickling) that is different from those examined in the present 
study. Nevertheless, the present results are of great relevance 
as they demonstrate, for the first time, that metyrapone affects 
the emission of 50-kHz USVs in stress-naïve rats. Moreover, the 
present results further elucidate the effects that metyrapone 
Figure 6. Effects of mifepristone on calling in rats treated with a low dose of 
amphetamine and individually housed during recordings. Co-administration 
of mifepristone (100 mg/kg, s.c.) had no influence on calling recorded after 
the administration of amphetamine (0.25 mg/kg, i.p.) in all rats and in the LV 
group (A–B). Conversely, mifepristone co-administration reduced the number 
of 50-kHz ultrasonic vocalizations (USVs) recorded after the administration of 
amphetamine in the HV group of rats (C). AMPH, amphetamine; HV, high vocali-
zation; LV, low vocalization; MIFE, mifepristone; VEH, vehicle. #P < .05 vs VEH + 
AMPH. n = 20 for all rats. n = 10 for the LV and HV groups of rats.
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may have on the emotional state of rats, and can contribute to 
the preclinical characterization of the anti-addiction and anti-
depressant properties of metyrapone, which have been previ-
ously described (Murphy, 1997; Healy et al., 1999; Goeders and 
Guerin, 2008; Guerin et al., 2014).
In conclusion, the present study further characterizes the 
mechanisms that regulate the emission of 50-kHz USVs and 
the interplay between glucocorticoid signaling and positive 
affect. The results obtained may help to define the usefulness 
of 50-kHz USVs in studying the modifications in the emotional 
state of rats that can be induced by natural and pharmacological 
rewards.
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